This past weekend at the American Academy of Allergy, Asthma and Immunology Conference (AAAAI), exciting findings from Clinical Trials of the Viaskin Peanut (Phase II) & Milk (Phase I/II) Patch were shared. I was honored to speak with Dr. Hugh Sampson, Chief Scientific Officer of DBV (the biopharmaceutical company behind Viaskin)  the week before the.. read more →